Which of the following types of bronchogenic carcinomas are most likely to develop within a residual area of peripheral scar tissue?
**Core Concept**
Adenocarcinoma of the lung is the most common type of bronchogenic carcinoma and has a strong association with smoking and peripheral scar tissue. The development of adenocarcinoma within residual areas of peripheral scar tissue is thought to be due to the field effect of smoking, which leads to genetic alterations in the bronchial epithelium.
**Why the Correct Answer is Right**
Adenocarcinoma arises from the peripheral bronchioles and alveoli, which are more prone to injury from smoking and subsequent scarring. The residual areas of peripheral scar tissue provide a fertile ground for the development of adenocarcinoma, which can arise from the remaining normal-appearing bronchial epithelium. This is in contrast to other types of bronchogenic carcinomas, such as squamous-cell carcinoma, which typically arise from the central airways.
**Why Each Wrong Option is Incorrect**
**Option A:** Small-cell carcinoma is a highly aggressive type of lung cancer that typically arises from the central airways and is associated with smoking, but it is not as strongly associated with peripheral scar tissue as adenocarcinoma.
**Option B:** Squamous-cell carcinoma is a type of lung cancer that typically arises from the central airways and is associated with smoking, but it is not as strongly associated with peripheral scar tissue as adenocarcinoma.
**Option C:** Large-cell carcinoma is a type of lung cancer that can arise from any part of the lung, but it is not as strongly associated with peripheral scar tissue as adenocarcinoma.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that adenocarcinoma of the lung is the most common type of bronchogenic carcinoma, and its development is strongly associated with smoking and peripheral scar tissue. This knowledge can help guide the clinical evaluation and management of patients with lung cancer.
**✓ Correct Answer: D. Adenocarcinoma**